Dominique Bories

Université Paris Est
Creteil, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

AML with inv(16)/t(16;16) and high-risk cytogenetic abnormalities: atypical features and unfavorable outcome.

AML with inv(16)/t(16;16) and high-risk cytogenetic abnormalities: atypical features and unfavorable outcome.

Journal: Hematology (Amsterdam, Netherlands)

Published: May 27, 2022

Successive relapses from donor and host cells in a patient with DEAD-box helicase 41 (DDX41)-associated myelodysplastic syndrome: The lessons to be learned.

Successive relapses from donor and host cells in a patient with DEAD-box helicase 41 (DDX41)-associated myelodysplastic syndrome: The lessons to be learned.

Journal: British journal of haematology

Published: May 24, 2022

Fusion Gene Detection and Quantification by Asymmetric Capture Sequencing (aCAP-Seq).

Fusion Gene Detection and Quantification by Asymmetric Capture Sequencing (aCAP-Seq).

Journal: The Journal of molecular diagnostics : JMD

Published: May 20, 2022

Leukaemic evolution of rare donor CSF3R germline mutation after umbilical cord blood transplant.

Leukaemic evolution of rare donor CSF3R germline mutation after umbilical cord blood transplant.

Journal: British journal of haematology

Published: January 24, 2022

Donor-Derived Myeloid Heme Oxygenase-1 Controls the Development of Graft-Versus-Host Disease.

Donor-Derived Myeloid Heme Oxygenase-1 Controls the Development of Graft-Versus-Host Disease.

Journal: Frontiers in immunology

Published: July 01, 2020

Extensive multilineage analysis in patients with mixed chimerism after allogeneic transplantation for sickle cell disease: insight into hematopoiesis and engraftment thresholds for gene therapy.

Extensive multilineage analysis in patients with mixed chimerism after allogeneic transplantation for sickle cell disease: insight into hematopoiesis and engraftment thresholds for gene therapy.

Journal: Haematologica

Published: May 24, 2019

Long-term event-free survival, chimerism and fertility outcomes in 234 patients with sickle-cell anemia younger than 30 years after myeloablative conditioning and matched-sibling transplantation in France.

Long-term event-free survival, chimerism and fertility outcomes in 234 patients with sickle-cell anemia younger than 30 years after myeloablative conditioning and matched-sibling transplantation in France.

Journal: Haematologica

Published: December 03, 2018

Acute mast cell leukemia: A rare but highly aggressive hematopoietic neoplasm.

Acute mast cell leukemia: A rare but highly aggressive hematopoietic neoplasm.

Journal: Diagnostic cytopathology

Published: January 16, 2018

Flow cytometry minimal residual disease after allogeneic transplant for chronic lymphocytic leukemia.

Flow cytometry minimal residual disease after allogeneic transplant for chronic lymphocytic leukemia.

Journal: European journal of haematology

Published: November 28, 2016

Face transplant: long-term follow-up and results of a prospective open study.

Face transplant: long-term follow-up and results of a prospective open study.

Journal: Lancet (London, England)

Published: August 29, 2016

Genetic hierarchy and temporal variegation in the clonal history of acute myeloid leukaemia.

Genetic hierarchy and temporal variegation in the clonal history of acute myeloid leukaemia.

Journal: Nature communications

Published: February 16, 2016

Clonal history of a cord blood donor cell leukemia with prenatal somatic JAK2 V617F mutation.

Clonal history of a cord blood donor cell leukemia with prenatal somatic JAK2 V617F mutation.

Journal: Leukemia

Published: February 16, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026